S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors

被引:2
作者
Mandarino, Angelo [1 ]
Thiyagarajan, Swetha [1 ]
Martins, Allana C. F. [1 ]
da Silva Gomes, Roberto [1 ]
Vetter, Stefan W. [1 ]
Leclerc, Estelle [1 ]
机构
[1] North Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA
关键词
S100; protein; HMGB1; pancreatic cancer; GLYCATION END-PRODUCTS; CALCIUM-BINDING PROTEIN; CELL-PROLIFERATION; EXPRESSION; RAGE; PROMOTES; INVASION; RECEPTOR; GROWTH; MIGRATION;
D O I
10.3390/biom13081175
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic cancer remains a disease that is very difficult to treat. S100 proteins are small calcium binding proteins with diverse intra- and extracellular functions that modulate different aspects of tumorigenesis, including tumor growth and metastasis. High mobility group box 1 (HMGB1) protein is a multifaceted protein that also actively influences the development and progression of tumors. In this study, we investigate the possible correlations, at the transcript level, between S100s and HMGB1 in pancreatic cancer. For this purpose, we calculated Pearson's correlations between the transcript levels of 13 cancer-related S100 genes and HMGB1 in a cDNA array containing 19 pancreatic cancer tumor samples, and in 8 human pancreatic cancer cell lines. Statistically significant positive correlations were found in 5.5% (5 out of 91) and 37.4% (34 of 91) of the possible S100/S100 or S100/HMGB1 pairs in cells and tumors, respectively. Our data suggest that many S100 proteins crosstalk in pancreatic tumors either with other members of the S100 family, or with HMGB1. These newly observed interdependencies may be used to further the characterization of pancreatic tumors based on S100 and HMGB1 transcription profiles.
引用
收藏
页数:16
相关论文
共 90 条
  • [11] Characterization of the Ca2+-regulated Ezrin-S100P Interaction and Its Role in Tumor Cell Migration
    Austermann, Judith
    Nazmi, Ali Reza
    Mueller-Tidow, Carsten
    Gerke, Volker
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (43) : 29331 - 29340
  • [12] S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma
    Bachet, Jean-Baptiste
    Marechal, Raphael
    Demetter, Pieter
    Bonnetain, Franck
    Cros, Jerome
    Svrcek, Magali
    Bardier-Dupas, Armelle
    Hammel, Pascal
    Sauvanet, Alain
    Louvet, Christophe
    Paye, Francois
    Vaillant, Jean-Christophe
    Andre, Thierry
    Closset, Jean
    Salmon, Isabelle
    Emile, Jean-Francois
    Van Laethem, Jean-Luc
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (12) : 2643 - 2653
  • [13] p52 signaling promotes cellular senescence
    Bernal, Giovanna M.
    Wu, Longtao
    Voce, David J.
    Weichselbaum, Ralph R.
    Yamini, Bakhtiar
    [J]. CELL AND BIOSCIENCE, 2022, 12 (01)
  • [14] Understanding RAGE, the receptor for advanced glycation end products
    Bierhaus, A
    Humpert, PM
    Morcos, M
    Wendt, T
    Chavakis, T
    Arnold, B
    Stern, DM
    Nawroth, PP
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (11): : 876 - 886
  • [15] S100 proteins in cancer
    Bresnick, Anne R.
    Weber, David J.
    Zimmer, Danna B.
    [J]. NATURE REVIEWS CANCER, 2015, 15 (02) : 96 - 109
  • [16] S100A10, a novel biomarker in pancreatic ductal adenocarcinoma
    Bydoun, Moamen
    Sterea, Andra
    Liptay, Henry
    Uzans, Andrea
    Huang, Weei-Yuarn
    Rodrigues, Gloria J.
    Weaver, Ian C. G.
    Gu, Hong
    Waisman, David M.
    [J]. MOLECULAR ONCOLOGY, 2018, 12 (11) : 1895 - 1916
  • [17] cancer.net, Pancreatic Cancer-Statistics
  • [18] Chen HY, 2014, AM J CANCER RES, V4, P89
  • [19] Involvement of S100A14 Protein in Cell Invasion by Affecting Expression and Function of Matrix Metalloproteinase (MMP)-2 via p53-dependent Transcriptional Regulation
    Chen, Hongyan
    Yuan, Yi
    Zhang, Chunpeng
    Luo, Aiping
    Ding, Fang
    Ma, Jianlin
    Yang, Shouhui
    Tian, Yanyan
    Tong, Tong
    Zhan, Qimin
    Liu, Zhihua
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (21) : 17109 - 17119
  • [20] High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway
    Cheng, Peng
    Ma, Yun
    Gao, Zhiqiang
    Duan, Lingling
    [J]. MEDICAL SCIENCE MONITOR, 2018, 24 : 8916 - 8924